Relief Therapeutics Holding AG

SIX:RLF.SW

2.355 (CHF) • At close June 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q42008 Q22007 Q42007 Q22006 Q42006 Q2
Revenue 2.8365.5813.013.0232.8393.2423.321000000.5670000.01500.1280.1289.7459.7459.74510.35700000.1930.1936.876.877.2737.2733.6367.4143.707-1.227
Cost of Revenue 4.6326.4848.158.7429.6398.4696.43200000.0010.05500.07100.21101.0021.0815.8796.8046.8047.3181.9040000000000000.43
Gross Profit -1.796-0.903-5.14-5.719-6.8-5.227-3.1110000-0.0010.5120-0.0710-0.1960-0.874-0.9533.8662.9412.9413.039-1.9040000.1930.1936.876.877.2737.2733.6367.4143.707-1.656
Gross Profit Ratio -0.633-0.162-1.708-1.892-2.395-1.612-0.937000000.903000-13.0670-6.823-7.4390.3970.3020.3020.29300001111111110.827
Reseach & Development Expenses 0.6240.7330.3950.9331.75610.63711.1997.82513.6720000000000000000.9520.95227.3527.357.2747.27410.07310.07310.08610.0865.0435.6462.8231.854
General & Administrative Expenses 001.9293.4623.7843.9632.5853.0652.4040.4340.390.1760.3990.2440.1520.5520.8980.0650.0140.0141.2840.9080.90801.861.861.3361.3360.8420.8421.0351.0350.5950.5950.2980.7540.377-0.377
Selling & Marketing Expenses 000.7581.4422.8420.4650.3653.92113.3893.0710.1050.2440.1680.1780.4760.5130.040.206-0.9430.943-8.0558.0858.08500.2780.2780.8980.8981.7021.7021.8161.8161.1751.1750.5881.8810.94-0.94
SG&A 1.1982.4152.6294.9046.5064.3133.3886.98615.7933.5050.4950.420.5670.4220.6281.0651.4560.271-0.9290.957-6.7718.9938.9931.6752.1382.1382.2342.2342.5432.5432.8512.8511.7711.7710.8852.6351.3182.199
Other Expenses 00-0.094-0.09-0.517-0.791-0.041-0.13900-0.03100000001.96501.312000-1.6860000000000000
Operating Expenses 1.8223.1483.1185.9278.77915.74114.62814.9515.7933.5050.5260.420.3660.4220.6921.0516.3440.2711.0360.95711.4848.9938.9931.6751.4043.0929.58429.5849.8179.81712.92412.92411.85711.8575.9298.2814.144.053
Operating Income -3.618-4.051-8.258-11.646-15.579-20.968-17.739-14.95-15.793-3.505-0.526-0.421-0.078-0.422-0.686-1.05-1.662-0.2710.741-4.56-5.878-6.226-6.226-6.194-2.937-3.242-29.75-29.418-9.75-9.498-6.16-5.948-4.859-4.31-2.155-0.555-0.278-5.866
Operating Income Ratio -1.276-0.726-2.744-3.852-5.487-6.468-5.34100000-0.138000-110.805.789-35.612-0.603-0.639-0.639-0.5980000-50.468-49.164-0.897-0.866-0.668-0.593-0.593-0.075-0.075-2.477
Total Other Income Expenses Net -11.7410.054-39.284-0.79-1.382-0.894-1.069-0.15-0.28913.326-11.08-0.1350.0270.057-0.146-0.019-0.323-0.002-2.3772.377-0.016-0.001-0.001-0.0244.21500.167-0.1650.052-0.2010.049-0.1630.158-0.39-0.195-0.327-0.164-0.705
Income Before Tax -15.359-3.997-47.542-64.142-26.207-28.109-20.858-14.667-16.0829.821-11.606-0.556-0.051-0.365-0.832-1.069-16.541-0.273-2.183-2.183-6.227-6.227-6.227-6.218-3.242-3.242-29.583-29.583-9.698-9.698-6.111-6.111-4.7-4.7-2.35-0.883-0.441-6.571
Income Before Tax Ratio -5.416-0.716-15.795-21.218-9.231-8.67-6.28100000-0.09000-1,102.7330-17.051-17.051-0.639-0.639-0.639-0.60000-50.201-50.202-0.889-0.889-0.646-0.646-0.646-0.119-0.119-2.827
Income Tax Expense -2.7970.56-5.86-7.643-1.917-1.609-0.8310.011-0.0031.57-4.70200.0200.98600.02-0.028-0.044-0.044-0.085-0.085-0.085-0.108-0.3180-0.1670.165-0.0520.201-0.004-0.004-0.1580.390.1950.1170.0590.141
Net Income -12.562-4.557-41.682-56.499-24.29-26.5-20.027-14.678-16.0798.251-6.904-0.556-0.071-0.365-1.818-1.069-16.561-0.273-7.015-2.14-6.139-6.141-6.141-6.11-3.242-3.242-29.418-29.748-9.498-9.899-6.107-6.107-4.31-5.09-2.545-1-0.5-6.725
Net Income Ratio -4.429-0.817-13.848-18.69-8.556-8.174-6.0300000-0.125000-1,104.0670-54.776-16.709-0.63-0.63-0.63-0.590000-49.163-51.24-0.889-0.889-0.593-0.7-0.7-0.135-0.135-2.913
EPS -1-0.36-3.32-5.1-2.25-2.55-2.1-1.76-2.831.54-1.31-0.11-0.014-0.073-0.37-0.21-3.51-0.17-6.237-0.003-10.327-0.013-0.013-0.036-37.153-0.047-342.96-0.44-116.652-0.018-9.009-0.011-7.171-0.039-0.02-0.01-0.005-43.295
EPS Diluted -1-0.36-3.32-5.1-2.25-2.55-2.1-1.76-2.831.54-1.31-0.11-0.014-0.073-0.37-0.21-3.51-0.17-6.237-0.003-10.327-0.013-0.013-0.036-37.153-0.047-342.96-0.44-116.652-0.018-9.009-0.011-7.171-0.039-0.02-0.01-0.005-43.295
EBITDA -14.208-2.518-45.853-62.349-24.321-26.032-32.380.964-15.7939.985-11.501-0.42-0.063-0.42-0.685-1.048-1.92303.424-3.505-0.958-5.063-5.063-5.2063.562-3.084-28.69-28.44-7.69-7.69-4.094-4.094-2.488-2.488-1.2441.1350.568-6.142
EBITDA Ratio -5.01-0.451-15.234-20.625-8.567-8.03-9.7500000-0.111000-128.2026.739-27.371-0.098-0.52-0.52-0.5030000-39.807-39.808-0.596-0.596-0.342-0.342-0.3420.1530.153-2.247